Tetracaine Hydrochloride is one of 26 small molecule programs targeting Sedation. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
30 competitors in Blood Pressure
Benicar
Intropin
Isoproterenol Hydrochloride
Robinul
Carbocaine
Chirocaine
Ephedrine Sulfate
Atropen
Pitressin
Glypressin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
Feb 29, 2016
TETRACAINE HYDROCHLORIDE
NDA NDA208135
Mar 12, 2019
TETRACAINE HYDROCHLORIDE
NDA NDA210821
Sources
Details